Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis.
Liu Y, Dong Y, Zhao L, Su L, Luo J.
Int J Oncol · journal article · DOI 10.3892/ijo.2018.4485 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för monastrol. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
12 hitsSynthesis and antitumoral activity of novel analogues monastrol-fatty acids against glioma cells.
De Oliveira FS, De Oliveira PM, Farias LM, Brinkerhoff RC, Sobrinho RCMA, Treptow TM, Montes D'Oca CR, Marinho MAG, Hort MA, Horn AP, Russowsky D, Montes D'Oca MG.
Medchemcomm · research-article; journal article · DOI 10.1039/c8md00169cEffect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines.
Gonçalves IL, Rockenbach L, das Neves GM, Göethel G, Nascimento F, Porto Kagami L, Figueiró F, Oliveira de Azambuja G, de Fraga Dias A, Amaro A, de Souza LM, da Rocha Pitta I, Avila DS, Kawano DF, Garcia SC, Battastini AMO, Eifler-Lima VL.
Medchemcomm · research-article; journal article · DOI 10.1039/c8md00095fMonastrol, a 3,4-dihydropyrimidin-2(1H)-thione, as structural scaffold for the development of modulators for GHB high-affinity binding sites and α<sub>1</sub>β<sub>2</sub>δ GABA<sub>A</sub> receptors.
Damgaard M, Al-Khawaja A, Nittegaard-Nielsen M, Petersen RF, Wellendorph P, Frølund B.
Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2017.06.024Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.
Bobylev I, Peters D, Vyas M, Barham M, Klein I, von Strandmann EP, Neiss WF, Lehmann HC.
Neurotox Res · journal article · DOI 10.1007/s12640-017-9760-7Comparison of the Effects of Monastrol and Oxomonastrol on Human Hepatoma Cell Line HepG2/C3A.
Marques LA, Semprebon SC, Sartori D, DE Fátima Â, Ribeiro LR, Mantovani MS.
Anticancer Res · comparative study; journal article · DOI 10.21873/anticanres.11434Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
Marques LA, Semprebon SC, Niwa AM, D'Epiro GF, Sartori D, de Fátima Â, Ribeiro LR, Mantovani MS.
Naunyn Schmiedebergs Arch Pharmacol · comparative study; journal article · DOI 10.1007/s00210-016-1292-9Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
Asraf H, Avunie-Masala R, Hershfinkel M, Gheber L.
PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0129255Centrin: another target of monastrol, an inhibitor of mitotic spindle.
Duan L, Wang TQ, Bian W, Liu W, Sun Y, Yang BS.
Spectrochim Acta A Mol Biomol Spectrosc · research support, non-u.s. gov't; journal article · DOI 10.1016/j.saa.2014.08.050Structure based virtual screening-driven identification of monastrol as a potent urease inhibitor.
Rashid U, Batool I, Wadood A, Khan A, ul-Haq Z, Chaudhary MI, Ansari FL.
J Mol Graph Model · journal article · DOI 10.1016/j.jmgm.2013.04.006A member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrol.
Kaur J, Dutta S, Chang KP, Singh N.
J Antimicrob Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/jac/dks507Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J, Sundar S, Singh N.
J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkq189